Successful Marketing of Guilin Pharma Artesun in Nigeria and Ghana

Recently, Fosun Pharmaceutical-Guilin Pharma has successfully held marketing conferences for the injection-purpose Artesunate Artesun, which is one of core products in Nigeria and Ghana located at Africa. This represents that such product has completely and formally entered into the markets of both counties and been observed as a medicine saving the lives and ideal choice for curing serious malaria by the medical experts in Nigeria.

Two marketing conferences are jointly sponsored by Guilin Pharma and the agents of both countries, in which the doctors and pharmacists from main public and private hospitals in Nigeria and Ghana are invited and the experts in anti-malarial field have introduced and explained clinical effects and lab basis of the Artesunate to cure the malaria respectively. The experts from Guilin Pharmaceutical have answered the questions of the participants at site and also agreed to an interview from local Medias. Formal marketing of this product is well received by the medical brotherhood and has brought high attention from social opinion.

Nigeria is not only the first country with large populations, but the case number of the malaria also ranks the first, the annual morbidity has been up to 5.7 million persons, among which about 5% refers to the cases of serious malaria. As a more developed country in West Africa, the annual malaria prevalence of Ghana is about 300 thousand persons, it is No.1 infectious disease there. Before the Artesun enters into local markets, these countries mainly take Quinine to cure serious malaria, but such machine has great side effect, even so many patients give up the treatment for unable to be intolerant or have a hangover from that. Though National Malaria Control Program in Nigeria has list the Artesunate available for Injection as primary medicine used for curing serious malaria, yet such medicine requires higher requirements for production technology, so this products haven t been introduced in local areas before entering the markets of Guilin Pharma- Artesun . At present, it starts to sell the Artesunate in Nigeria so as to provide a new choice for the local areas to cure serious malaria, meanwhile, it has been observed as A Medicine Saving the Lives and Ideal Choice for Curing Serious Malaria by the medical experts in this country.

According to the briefing, the Artesun refers to lyophilized powder injection of the Artesunate researched and developed by Guilin Pharma, compared with the Quinine as traditional medicine to cure serious malaria, this features quick effect, obvious curative effect and lower side effects. In the Guidelines for the Treatment of Malaria (WHO, 2006), this medicine has been recommended as one of first choices to cure serious and malignant malaria by WHO. So far, it has acquired registration nearly from 20 counties in Africa and entered into the markets on sale.